INS Share PerformanceMore
|52 week high||328.55 26/09/16|
|52 week low||171.00 04/05/17|
|52 week change||-42.50 (-18.28%)|
|4 week volume||25,013 29/06/17|
Media for (INS)
Latest News« previous» nextMore
17/07/2017 - 11:27 RNS
RNS Number: 2507L Instem plc 17 July 2017 Instem plc (" Instem " or the " Company ") Issue of Equity, Total Voting Rights and PDMR Dealing Instem plc (AIM: INS), a leading provider of IT solutions to the global early development healthcare market, announces that, following the exercise of vested EMI share options by an employee, 1,500 ordinary shares of 10p ea...
31/05/2017 - 08:39 RNS
RNS Number: 6631G Instem plc 31 May 2017 Instem plc ("Instem" or the "Company") Samarind Deferred Consideration Payment and Total Voting Rights Instem (AIM: INS), a leading provider of IT solutions to the global early development healthcare market, announces that the first deferred consideration payment of 450,000 in respect of the acquisition of Samarind...
19/05/2017 - 17:00 RNS
RNS Number: 7279F Instem plc 19 May 2017 TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES i 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii INSTEM PLC 2 Reason for the notification (please tick the appropriate box or boxes): An acquisition or disposal of voting rights X An acquisition or disposal o...
18/05/2017 - 14:59 StockMarketWire
Instem has announced that, at its Annual General Meeting held earlier today, all resolutions were passed. At 2:59pm: (LON:I...
18/05/2017 - 10:24 RNS
RNS Number: 5426F Instem plc 18 May 2017 Instem plc ("Instem") Result of Annual General Meeting Instem plc (AIM: INS.L), a leading provider ofIT solutionsto the global early development healthcare market,announces that at its Annual General Meeting, held today, all resolutions were duly passed. For further information, please contact: Instem plc +44 (0) 1785 825...
28/04/2017 - 17:12 RNS
RNS Number: 7761D Instem plc 28 April 2017 TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES i 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii Instem PLC 2 Reason for the notification (please tick the appropriate box or boxes): An acquisition or disposal of voting rights X An acquisition or disposal o...
26/04/2017 - 07:00 RNS
RNS Number: 3281D Instem plc 26 April 2017 Instem plc ("Instem") US Government Contract Further to the statement in the preliminary results announced on 28 th March, the Company's auditors have confirmed that the accounting treatment for the contract with the US National Institute of Environmental Health Sciences (NIEHS) awarded in early 2017 will be t...
21/04/2017 - 09:29 StockMarketWire
Instem will hold its annual general meeting at the offices of RSM, 3 Hardman Street, Manchester, M3 3HF, on 18 May at 10...
|Dividend yield||0 %|
Equity Research (INS)
Instem’s FY 16A results were line with the Jan-17 trading update and our forecasts. Excluding the Clinical business, performance remains solid, particularly in pre-clinical and the SEND businesses....
Instem has published a short trading update for the year to December 2016. The outcome was in line with (and in some areas slightly ahead of) our expectations. The year was impacted by the slowdown...
Instem recently confirmed that its Instem Clinical business continues to be impacted by a slowdown in the early-phase clinical market and, despite other areas of Instem performing well, that this...
- 1 of 5
Latest discussion posts More
“"I first spoke to LSE:INS:Instem early last year. The AIM-listed company was worth A#22 million and demand for its software, which helps drug companies develop commercial drugs ...”▼
Codes & Symbols
|Symbols||INS, LSE:INS, INS.L, INS:LN, LON:INS, XLON:INS|